Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV
· Real-Time Price · USD
1.82
0.04 (2.25%)
At close: Aug 15, 2025, 3:59 PM
1.91
4.95%
After-hours: Aug 15, 2025, 07:55 PM EDT
Enlivex Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.28M | 2.28M | 2.28M |
Cost of Revenue | 447K | 545K | 709K | 762K | 814K | 835K | 856K | 834K | 798K | 777K | 706K | 671K | 617K | 546K | 496K | 431K | 369K |
Gross Profit | -447K | -545K | -709K | -762K | -814K | -835K | -856K | -834K | -798K | -777K | -706K | -671K | -617K | -546K | -496K | -431K | -369K |
Operating Income | -15.27M | -15.69M | -16.15M | -18.66M | -22.32M | -25.15M | -26.91M | -26.95M | -26.18M | -25.8M | -25.77M | -23.95M | -21.89M | -19.29M | -15.17M | -13.27M | -11.69M |
Interest Income | 537K | 467K | 11K | 11K | 11.42K | 422.00 | 422.00 | 422.00 | n/a | n/a | n/a | n/a | n/a | n/a | 225K | 282K | 371K |
Pretax Income | -14.33M | -15.01M | -18.93M | -22.29M | -25.99M | -29.07M | -27.16M | -26.93M | -30.05M | -31.06M | -28.61M | -26.3M | -19.49M | -14.47M | -15.6M | -14.3M | -14.23M |
Net Income | -14.33M | -15.01M | -18.93M | -22.29M | -25.99M | -29.07M | -27.16M | -26.93M | -30.05M | -31.06M | -28.61M | -26.3M | -19.49M | -14.47M | -15.6M | -14.3M | -14.23M |
Selling & General & Admin | 4.67M | 4.81M | 3.58M | 4.09M | 4.72M | 5.23M | 6.24M | 6.44M | 6.59M | 6.7M | 7.44M | 7.15M | 6.66M | 6.24M | 5.21M | 4.78M | 4.38M |
Research & Development | 10.32M | 10.62M | 11.66M | 13.66M | 16.69M | 19.01M | 20.26M | 20.11M | 19.19M | 18.69M | 18.16M | 16.64M | 15.07M | 12.88M | 9.87M | 8.39M | 7.21M |
Other Expenses | 285K | 256K | n/a | -335K | -478K | -913K | -511K | -232K | -4.13M | -5.52M | -5.75M | -5.26M | -514K | 1.91M | 1.74M | 1.3M | 602K |
Operating Expenses | 15.27M | 15.5M | 15.76M | 18.27M | 21.93M | 24.95M | 26.91M | 26.95M | 26.18M | 25.8M | 25.77M | 23.95M | 21.89M | 19.29M | 15.17M | 13.27M | 11.69M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 435K | 435K | 491K | 4.53M | 5.92M | 5.92M | 5.86M | 1.82M | n/a | n/a | 223K | 1.12M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.09M | 15.54M | 16.15M | 13.03M | 16.69M | 19.52M | 21.28M | 26.95M | 26.18M | 25.8M | 25.77M | 23.95M | 21.89M | 19.29M | 15.17M | 13.27M | 11.69M |
Income Tax Expense | n/a | n/a | 156.19K | 156.19K | 156.19K | 156.19K | n/a | 56K | 56K | 56K | 56K | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 21.9M | 21.9M | 21.28M | 19.55M | 18.73M | 18.6M | 18.6M | 18.58M | 18.52M | 18.42M | 18.39M | 18.38M | 18.37M | 18.31M | 18.31M | 18.31M | 16.48M |
Shares Outstanding (Diluted) | 21.9M | 21.9M | 21.28M | 19.55M | 18.73M | 18.6M | 18.6M | 18.58M | 18.52M | 18.42M | 18.39M | 18.38M | 18.37M | 18.31M | 18.31M | 18.31M | 16.48M |
EPS (Basic) | -0.68 | -0.74 | -0.99 | -1.19 | -1.4 | -1.59 | -1.45 | -1.44 | -1.83 | -1.97 | -1.88 | -1.76 | -1.17 | -0.81 | -0.99 | -0.96 | -1.02 |
EPS (Diluted) | -0.68 | -0.74 | -0.99 | -1.19 | -1.4 | -1.59 | -1.45 | -1.44 | -1.83 | -1.97 | -1.88 | -1.76 | -1.17 | -0.81 | -0.99 | -0.96 | -1.02 |
EBITDA | -14.34M | -14.69M | -15.44M | -17.89M | -21.5M | -24.32M | -26.05M | -26.12M | -25.38M | -25.02M | -25.06M | -23.28M | -21.27M | -18.74M | -14.66M | -12.84M | -11.33M |
EBIT | -14.79M | -15.23M | -16.15M | -18.66M | -22.32M | -25.15M | -26.91M | -26.95M | -26.18M | -25.8M | -25.77M | -23.95M | -21.89M | -19.29M | -15.38M | -13.48M | -11.9M |
Depreciation & Amortization | 447K | 545K | 709K | 762K | 814K | 835K | 856K | 834K | 798K | 777K | 706K | 671K | 617K | 546K | 496K | 411K | 349K |